| Targeting ion channels for cancer therapy by repurposing the approved drugs VP Kale, SG Amin, MK Pandey Biochimica et Biophysica Acta (BBA)-Biomembranes 1848 (10), 2747-2755, 2015 | 97 | 2015 |
| Neuroglial expression of the MHCI pathway and PirB receptor is upregulated in the hippocampus with advanced aging HDVG Starkey, CA Van Kirk, GV Bixler, CG Imperio, VP Kale, JM Serfass, ... Journal of molecular neuroscience 48, 111-126, 2012 | 71 | 2012 |
| Effect of fasting duration on clinical pathology results in Wistar rats VP Kale, GS Joshi, PB Gohil, MR Jain Veterinary Clinical Pathology 38 (3), 361-366, 2009 | 56 | 2009 |
| Gambogic acid inhibits multiple myeloma mediated osteoclastogenesis through suppression of chemokine receptor CXCR4 signaling pathways MK Pandey, VP Kale, C Song, S Sung, AK Sharma, G Talamo, S Dovat, ... Experimental hematology 42 (10), 883-896, 2014 | 53 | 2014 |
| The regulatory roles of ROCK and MRCK kinases in the plasticity of cancer cell migration VP Kale, JA Hengst, DH Desai, SG Amin, JK Yun Cancer letters 361 (2), 185-196, 2015 | 50 | 2015 |
| The apoptotic mechanism of action of the sphingosine kinase 1 selective inhibitor SKI-178 in human acute myeloid leukemia cell lines TE Dick, JA Hengst, TE Fox, AL Colledge, VP Kale, SS Sung, A Sharma, ... Journal of Pharmacology and Experimental Therapeutics 352 (3), 494-508, 2015 | 48 | 2015 |
| Old drugs, new uses: Drug repurposing in hematological malignancies VP Kale, H Habib, R Chitren, M Patel, KC Pramanik, SC Jonnalagadda, ... Seminars in cancer biology 68, 242-248, 2021 | 38 | 2021 |
| Effect of repeated freezing and thawing on 18 clinical chemistry analytes in rat serum VP Kale, SG Patel, PS Gunjal, SU Wakchaure, RS Sundar, RK Ranvir, ... Journal of the American Association for Laboratory Animal Science 51 (4 …, 2012 | 35 | 2012 |
| A novel selective multikinase inhibitor of ROCK and MRCK effectively blocks cancer cell migration and invasion VP Kale, JA Hengst, DH Desai, TE Dick, KN Choe, AL Colledge, ... Cancer letters 354 (2), 299-310, 2014 | 30 | 2014 |
| Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis VP Kale, S Gibbs, JA Taylor, A Zmarowski, J Novak, K Patton, B Sparrow, ... Regulatory Toxicology and Pharmacology 109, 104483, 2019 | 21 | 2019 |
| Evaluation of adverse effects of lisinopril and rosuvastatin on hematological and biochemical analytes in wistar rats H Dodiya, V Kale, S Goswami, R Sundar, M Jain Toxicology international 20 (2), 170, 2013 | 13 | 2013 |
| Role of gambogic acid in chemosensitization of cancer VP Kale, PJ Gilhooley, S Phadtare, A Nabavizadeh, MK Pandey Role of Nutraceuticals in Cancer Chemosensitization, 151-167, 2018 | 10 | 2018 |
| Targeting CXCL12/CXCR4 axis in multiple myeloma MK Pandey, S Rastogi, VP Kale, T Gowda, SG Amin J. Hematol. Thromboembol. Diseases 2 (05), 2014 | 10 | 2014 |
| Evaluation of chronic toxicity of cyclocreatine, a creatine analog, in Sprague Dawley rat after oral gavage administration for up to 26 weeks VP Kale, J Wallery, J Novak, S Gibbs, M Bourdi, MHT Do, JC McKew, ... Regulatory Toxicology and Pharmacology 117, 104750, 2020 | 6 | 2020 |
| Evaluation of chronic toxicity of cyclocreatine, a creatine analog VP Kale, J Wallery, J Novak, S Gibbs, M Bourdi, MHT Do, JC McKew, ... Sprague Dawley rat after oral gavage administration for up to 26, 2020 | 6 | 2020 |
| Practical Considerations in Determining Adversity and the No-Observed-Adverse-Effect-Level (NOAEL) in Nonclinical Safety Studies: Challenges, Perspectives and Case Studies VP Kale, I Bebenek, H Ghantous, J Kapeghian, BP Singh, LJ Thomas International Journal of Toxicology 41 (2), 143-162, 2022 | 4 | 2022 |
| Role of Nutraceuticals in Chemoresistance to Cancer VP Kale, PJ Gilhooley, S Phadtare, A Nabavizadeh, MK Pandey Elsevier, 2018 | 4 | 2018 |
| Evaluation of chronic toxicity of cyclocreatine in beagle dogs after oral gavage administration for up to 23 weeks JJ Wallery, VP Kale, J Novak, S Gibbs, MHT Do, JC McKew, PS Terse Toxicology and applied pharmacology 430, 115680, 2021 | 2 | 2021 |
| Targeting Heat Shock Proteins in Multiple Myeloma VP Kale, S Phadtare, SG Amin, MK Pandey Heat Shock Proteins in Signaling Pathways, 233-251, 2019 | 1 | 2019 |
| DJ4, a novel ROCK and MRCK inhibitor, potently inhibits migration and invasion of cancer cells VP Kale, D Desai, T Dick, K Choe, A Colledge, S Amin, J Hengst, J Yun Cancer Research 74 (19_Supplement), 736-736, 2014 | 1 | 2014 |
Arun SharmaAssociate Professor of Pharmacology, Penn State College of MedicineVerified email at psu.edu
